2h
Inquirer Opinion on MSNGame-changer for pharmaceuticalsResearchers from the University of the Philippines Manila recently developed a cost-effective painkiller made from an herbal ...
How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.
In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, details the Biosecure Act, including the ways pharma ...
The number of workers in manufacturing has declined, but not because America stopped making things. It's because we got ...
We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...
Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up ...
The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful ...
The integration of AI and cloud technologies is transforming pharmaceutical manufacturing regulations, focusing on safety, efficiency, and global harmonization.
Trump's proposed tariffs on the EU would increase manufacturing costs for pharma companies and would stall medical innovation ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...
After threatening to impose “25% or higher” tariffs on foreign-made pharmaceuticals along with automobiles and semiconductors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results